Immunoprecise Antibodies Ltd Share Price

NASDAQ: IPA

$2.09

+0.16

(+8.29%)

as on September 4, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 29 Aug 2025

Immunoprecise Antibodies Ltd Stock Performance

as on September 4, 2025 at 1:29 am IST

Day's Low
Day's High
$2.05
Day's Price Range
$2.24
$2.09
1.91%
Downside
7.18%
Upside
52 Week's Low
52 Week's High
$0.27
52-Week Price Range
$3.25
$2.09
87.08%
Downside
55.31%
Upside

Immunoprecise Antibodies Ltd share price movements today

Previous Close: $1.93
Open: $2.09
Volume: 2.0M
Day's Low - High: $2.05 - $2.24
52 Week Low - High: $0.27 - $3.25

Immunoprecise Antibodies Ltd Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Immunoprecise Antibodies Ltd Stock Fundamentals & Key Indicators

Check Immunoprecise Antibodies Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Immunoprecise Antibodies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunoprecise Antibodies Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immunoprecise Antibodies Ltd	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Analyst Recommendation on Immunoprecise Antibodies Ltd Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Immunoprecise Antibodies Ltd. Average target price of $4

Immunoprecise Antibodies Ltd Share Price Target

Get share price movements and forecasts by analysts on Immunoprecise Antibodies Ltd.

What analysts predicted

47.75%UPSIDE

Target Price

Current Price

$2.09

Analyzed by

6 Analysts

Target

$4.00

Immunoprecise Antibodies Ltd target price $4, a slight upside of 47.75% compared to current price of $2.09. According to 6 analysts rating.

Immunoprecise Antibodies Ltd Stock's Interest Amongst Investors

Investment in Immunoprecise Antibodies Ltd Shares on INDmoney has grown by 13.72% over the past 30 days, indicating increased transactional activity.

Time period: August 16, 2025 to September 15, 2025

Change:13.72% versus previous 30 day period

Immunoprecise Antibodies Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2023	Apr 2023	Jul 2023	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Total Revenue	3	4	4	4	4	4	3	4	4	4
Gross Profit	2	2	2	2	2	2	1	2	2	3
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-2	-1	-1	-13	-2	-1	-14	-1
Net Profit Margin	-90.87%	-91.25%	-60.06%	-42.63%	-43.06%	-279.38%	-75.98%	-41.68%	-349.88%	-30.96%

Immunoprecise Antibodies Ltd Annual Profit & Loss

All numbers in Millions USD

	Apr 2016	Apr 2017	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Total Revenue	1	1	4	8	10	14	15	15	17	17
Gross Profit	1	1	1	3	5	9	8	8	8	9
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	0	-4	-4	-5	-3	-5	-13	-19	-19	-21
Net Profit Margin	7.97%	-204.64%	-95.04%	-69.71%	-35.19%	-40.98%	-86.29%	-128.53%	-110.85%	-123.30%

Global Institutional Holdings in Immunoprecise Antibodies Ltd

Funds	Holdings
Ingalls & Snyder LLC	6.02%
Susquehanna International Group, LLP	1.52%
Two Sigma Investments LLC	0.2%
Virtu Financial LLC	0.13%
CIBC World Markets Inc.	0.09%

See all

Insights on Immunoprecise Antibodies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, IPA stock has moved up by 246.1%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 5.26M → 6.98M (in $), with an average increase of 8.8% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, IPA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -21.52M → -2.16M (in $), with an average increase of 895.9% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 99.5% return, outperforming this stock by 162.5%

About Immunoprecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research company. It is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. It is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

Organisation	Immunoprecise Antibodies Ltd
E-voting on shares	Click here to vote

FAQs

What is Immunoprecise Antibodies Ltd share price today?

Immunoprecise Antibodies Ltd share price today is $2.09 as on September 4, 2025 at 1:29 am IST at the close of the market. Immunoprecise Antibodies Ltd share today touched a day high of $2.24 and a low of $2.05.

What is the 52 week high and 52 week low for Immunoprecise Antibodies Ltd share?

Immunoprecise Antibodies Ltd share touched a 52 week high of $3.25 on August 25, 2025 and a 52 week low of $0.27 on March 4, 2025. Immunoprecise Antibodies Ltd stock price today i.e. September 4, 2025 at 1:29 am IST is closed at $2.09,which is 35.61% down from its 52 week high and 674.07% up from its 52 week low.

How to invest in Immunoprecise Antibodies Ltd Stock (IPA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immunoprecise Antibodies Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunoprecise Antibodies Ltd Shares that will get you 0.7177 shares as per Immunoprecise Antibodies Ltd share price of $2.09 per share as on September 4, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunoprecise Antibodies Ltd Stock (IPA) from India?

Indian investors can start investing in Immunoprecise Antibodies Ltd (IPA) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 3:54 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Immunoprecise Antibodies Ltd stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 3:54 am IST). Based on Immunoprecise Antibodies Ltd share’s latest price of $2.09 as on September 4, 2025 at 1:29 am IST, you will get 4.7847 shares of Immunoprecise Antibodies Ltd. Learn more about fractional shares .